Impact of adrenomedullin on mitochondrial respiratory capacity in human adipocyte.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
13 06 2023
Historique:
received: 17 02 2023
accepted: 07 06 2023
medline: 15 6 2023
pubmed: 14 6 2023
entrez: 13 6 2023
Statut: epublish

Résumé

Mitochondrial function in adipocyte is an important aspect in maintaining metabolic homeostasis. Our previous observation showed that circulating levels of adrenomedullin (ADM) and mRNA and protein for ADM in omental adipose tissue were higher in patients with gestational diabetes mellitus (GDM), and these alterations are accompanied by glucose and lipid metabolic dysregulation, but the impact of ADM on mitochondrial biogenesis and respiration in human adipocyte remain elusive. The present study demonstrated that: (1) Increasing doses of glucose and ADM inhibit human adipocyte mRNA expressions of mitochondrial DNA (mtDNA)-encoded subunits of electron transport chain, including nicotinamide adenine dinucleotide dehydrogenase (ND) 1 and 2, cytochrome (CYT) b, as well as ATPase 6; (2) ADM significantly increases human adipocyte mitochondrial reactive oxygen species generation and this increase is reversed by ADM antagonist, ADM22-52, but treatment with ADM does not significantly affect mitochondrial contents in the adipocytes; (3) Adipocyte basal and maximal oxygen consumption rate are dose-dependently suppressed by ADM, thus results in impaired mitochondrial respiratory capacity. We conclude that elevated ADM observed in diabetic pregnancy may be involved in glucose and lipid dysregulation through compromising adipocyte mitochondrial function, and blockade of ADM action may improve GDM-related glucose and adipose tissue dysfunction.

Identifiants

pubmed: 37311963
doi: 10.1038/s41598-023-36622-2
pii: 10.1038/s41598-023-36622-2
pmc: PMC10264416
doi:

Substances chimiques

Adrenomedullin 148498-78-6
Cytochromes b 9035-37-4
DNA, Mitochondrial 0
Glucose IY9XDZ35W2
Lipids 0
RNA, Messenger 0
ADM protein, human 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

9578

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL058144
Pays : United States
Organisme : NICHD NIH HHS
ID : R21 HD091503
Pays : United States
Organisme : NIH HHS
ID : HD091503 and HL58144 to CY
Pays : United States

Commentaires et corrections

Type : UpdateOf

Informations de copyright

© 2023. The Author(s).

Références

Vasc Med. 2014 Feb;19(1):67-74
pubmed: 24558030
Peptides. 1999 Dec;20(12):1471-8
pubmed: 10698123
Diabetes Care. 2009 Apr;32(4):677-9
pubmed: 19131470
Hypertens Res. 2002 Nov;25(6):887-92
pubmed: 12484513
Diabetes. 2004 Jun;53(6):1412-7
pubmed: 15161742
N Engl J Med. 2004 Feb 12;350(7):639-41
pubmed: 14960738
Front Cardiovasc Med. 2020 Feb 25;7:22
pubmed: 32158768
Lancet. 1997 Nov 15;350(9089):1449-50
pubmed: 9371176
Metabolism. 2020 Jun;107:154193
pubmed: 32119876
FEBS Lett. 2003 Aug 28;550(1-3):163-7
pubmed: 12935904
J Clin Endocrinol Metab. 2018 Oct 1;103(10):3810-3818
pubmed: 30020508
FEBS J. 2013 Feb;280(4):1039-50
pubmed: 23253816
Front Physiol. 2020 Oct 30;11:578966
pubmed: 33192583
J Clin Endocrinol Metab. 2017 Sep 1;102(9):3425-3436
pubmed: 28666334
Annu Rev Pharmacol Toxicol. 2016;56:229-49
pubmed: 26566156
Nature. 1981 Apr 9;290(5806):457-65
pubmed: 7219534
Mol Cell Biol. 2003 Feb;23(3):1085-94
pubmed: 12529412
J Lipid Res. 2005 Jun;46(6):1133-49
pubmed: 15741651
Clin Liver Dis. 2014 Feb;18(1):41-58
pubmed: 24274864
J Clin Endocrinol Metab. 2019 Mar 1;104(3):697-706
pubmed: 30383252
Annu Rev Biochem. 2015;84:631-57
pubmed: 25839341
Diabetologia. 2006 Apr;49(4):784-91
pubmed: 16501941
ACS Chem Biol. 2014 Mar 21;9(3):777-84
pubmed: 24397822
J Proteome Res. 2011 Oct 7;10(10):4692-702
pubmed: 21815628
Science. 2005 Jan 21;307(5708):384-7
pubmed: 15662004
Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):830-6
pubmed: 24482374
Free Radic Biol Med. 2002 May 1;32(9):804-12
pubmed: 11978482
Cell Metab. 2012 Dec 5;16(6):765-76
pubmed: 23168219
Am J Physiol Endocrinol Metab. 2005 Jan;288(1):E56-62
pubmed: 15315911

Auteurs

Yuanlin Dong (Y)

Basic Sciences Perinatology Research Laboratories, Department of Obstetrics and Gynecology, Baylor College of Medicine/Texas Children's Hospital, 1102 Bates Street, Room #1850.34, Houston, TX, 77030, USA.

Vidyadharan Alukkal Vipin (VA)

Basic Sciences Perinatology Research Laboratories, Department of Obstetrics and Gynecology, Baylor College of Medicine/Texas Children's Hospital, 1102 Bates Street, Room #1850.34, Houston, TX, 77030, USA.

Chellakkan Selvanesan Blesson (CS)

Basic Sciences Perinatology Research Laboratories, Department of Obstetrics and Gynecology, Baylor College of Medicine/Texas Children's Hospital, 1102 Bates Street, Room #1850.34, Houston, TX, 77030, USA.

Chandrasekhar Yallampalli (C)

Basic Sciences Perinatology Research Laboratories, Department of Obstetrics and Gynecology, Baylor College of Medicine/Texas Children's Hospital, 1102 Bates Street, Room #1850.34, Houston, TX, 77030, USA. cyallamp@bcm.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH